Endocrinology: Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist

Human Reproduction

Volumn 8, Issue 12, 1993, Pages 2027-2032

  Donderwinkel, P F J ^b   Schoot, D C ^b   Pache, T D ^b   De Jong, F H ^a   Hop, W C J ^a   Fauser, B C J M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Erasmus University ^*

Author keywords

Exogenous gonadotrophins; GnRH a; Luteal function; Ovulation induction; Polycystic ovary syndrome

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; NORMAL HUMAN; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PROGESTERONE BLOOD LEVEL;

ADULT; BUSERELIN; CHORIONIC GONADOTROPIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMAN; LUTEAL PHASE; LUTEINIZING HORMONE; MENOTROPINS; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; REFERENCE VALUES;

EID: 0027729727     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a137976     Document Type: Article

References (28)

1. Bachus, K. E., Hughes, C. L., Haney, A. F. and Dodson, W. C. (1990) The luteal phase in polycystic ovarian syndrome during ovulation induction with human menopausal gonadotrophin with and without leuprolide acetate. Fertil. Steril., 54, 27 -31.
2. Belaisch-Allart, J., Testart, J., Fries, N., Forman, R. G. and Frydman, R. (1987) The effect of dydrogesterone supplementation in an IVF programme. Hum. Reprod., 2, 183 - 185.
3. Bider, D., Ben-Rafael, Z., Shalev, J., Goldenberg, M., Mashiach, S. and Blankstein, J. (1989) Pituitary and ovarian suppression rate after high dosage of gonadotropin-releasing hormone agonist. Fertil. Steril., 51, 578-581.
4. Brogden, R. N., Buckley, M. M.-T. and Ward, A. (1990) Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile. Drugs, 39, 399-437.
5. Calogero, A. E., Macchi, M., Montanini, V., Mongioi, A., Maugeri, G., Vicari, E., Coniglione, F., Sipione, C. and D'Agata, R. (1987) Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin releasing hormone. J. Clin. Endocrinol. Metab., 64, 980-985.
6. Cohen, J. J., Debache, C., Pigeau, F., Mandelbaum, J., Plachot, M. and De Brux, J. (1984) Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles. Fertil. Steril., 42, 360-365.
7. de Jong, F. H., Baird, D. T. and van der Molen, H. J. (1974) Ovarian secretion rates of oestrogens, androgens and progesterone in normal women and in women with persistent ovarian follicles. Acta Endocrinol., 77, 575-587.
8. Dodson, W. C., Hughes, C. L., Whitesides, D. B. and Haney, A. F. (1987) The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 65, 95 -100.
9. Fauser, B. C. J. M., Bogers, J. W., Hop, W. C. J. and de Jong, F. H. (1990) Bioactive and immunoreactive FSH in serum of normal and oligo- spermic men. Clin. Endocrinol. (Oxf.), 32, 433 -442.
10. Fauser, B. C. J. M., Pache, T. D., Lamberts, S. W. J., Hop, W. C. J., de Jong, F. H. and Dahl, K. D. (1991) Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with and without polycystic ovarian disease. J. Clin. Endocrinol. Metab., 73, 811-817.
11. Ferriman, D. and Gallwey, J. D. (1961) Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440-1447.
12. Ho Yuen, B., Sy, L. and Cannon, W. (1981) Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotrophins in anovulatory infertility. Am, J. Obstet. Gynecol., 140, 629 -635.
13. Insler, V. (1992) Corpus luteum defects. Curr. Opin. Obstet. Gynecol., 4, 203 -211.
14. Kyle, C. V., Griffin, J., Jarrett, A. and Odell, W. D. (1989) Inability to demonstrate an ultrashort loop feedback mechanism for luteinizing hormone in humans. J. Clin. Endocrinol. Metab., 69, 170-176.
15. Lemay, A., Sandow, J., Quesnel, G., Bergeron, J. and M6rat, P. (1988) Escape from down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist Fertil. Steril., 49, 802 - 808.
16. Loumaye, E. (1990) The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonist during ovarian hyperstimulation for in-vitro-fertilization and embryo transfer. Hum. Reprod., 5, 357-376.
17. Messinis, I. E., Bergh, T. and Wide, L. (1988) The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility. Fertil. Steril., 50, 31-35.
18. Messinis, I. E., Hirsch, P. and Templeton, A. (1991) Follicle stimulating hormone stimulates the production of gonadotrophin surge attenuating factor [GnSAF] in vivo. Clin. Endocrinol. (Oxf.), 35, 403-407.
19. Mizunuma, H., Takagi, T., Yamada, K., Andoh, K., Ibuki, Y. and Igarashi, M. (1991) Ovulation induction by step down administration of purified follicle-stimulating hormone in patients with polycystic ovarian syndrome. Fertil. Steril., 55, 1195 - 1196.
20. Olson, J. L., Rebar, R. W., Schreiber, J. F. and Vaitukaitis, J. L. (1993) Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin. Fertil. Steril., 39, 284-291.
21. Pache, T. D., Wladimiroff, J. W., Hop, W. C. J. and Fauser, B. C. J. M. (1992) How to discriminate between normal and polycystic ovaries. Radiology, 183, 421-423.
22. Rizkallah, T., Gurpide, E. and Vande Wiele, R. L. (1969) Metabolism of HCG in man. J. Clin. Endocrin. Metab., 29, 92 - 100.
23. Saal, W., Glowania, H.-J., Hengst, W. and Happ, J. (1991) Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin. Fertil. Steril., 56, 225 -229.
24. Schenken, R. S. and Hodgen, G. D. (1986) Follicle-stimulating hormone blocks estrogen-positive feedback during the early follicular phase in monkeys. Fertil. Steril., 45, 556 - 560.
25. Schoot, D. C., Pijlman, B., Stijnen, T. and Fauser, B. C. J. M. (1992a) Effects of gonadotropin releasing hormone agonist addition to gonadotropin induction of ovulation in polycystic ovary syndrome patients. Eur, J. Obstet. Gynecol. Reprod. Biol., 45, 53-58.
26. Schoot, D. C., Pache, T. D., Hop, W. C., de Jong, F. H. and Fauser, B. C. J. M. (1992b) Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome. Fertil. Steril., 57, 1117-1120.
27. Smitz, J., Devroey, P., Braeckmans, P., Camus, M., Khan, I., Staessen, C., Van Waesberghe, L., Wisanto, A. and Van Steirteghem, A. C. (1987) Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Hum. Reprod., 2, 309 -314.
28. Ziecik, A. J., Britt, J. H. and Esbenshade, K. L. (1988) Short loop feedback control of the estrogen-induced luteinizing hormone surge in pigs. Endocrinology, 122, 1658 - 1662.